Integra Lifesciences Holdings (IART) Non-Current Assets (2009 - 2026)

Integra Lifesciences Holdings' Non-Current Assets history runs 18 years deep, the most recent figure standing at $2.4 billion for Q1 2026.

• In Q1 2026, Non-Current Assets fell 18.33% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $9.9 billion (down 16.51% YoY), while the FY2025 annual figure was $2.4 billion, down 17.37% from the prior year.
• Non-Current Assets came in at $2.4 billion for Q1 2026 at Integra Lifesciences Holdings, down from $2.4 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3.0 billion in Q3 2024 to a low of $2.4 billion in Q1 2026.
• A 5-year average of $2.7 billion and a median of $2.7 billion in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets increased 10.63% in 2025 and dropped 18.33% in 2026, its largest moves.
• Integra Lifesciences Holdings' Non-Current Assets stood at $2.7 billion in 2022, then dropped by 0.16% to $2.7 billion in 2023, then climbed by 8.51% to $3.0 billion in 2024, then declined by 17.37% to $2.4 billion in 2025, then fell by 1.5% to $2.4 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $2.4 billion, $2.4 billion, and $2.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison